ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
36334.1 IP-LS
Project title
Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Professor Doktor
Gilbert Greub
CHUV
Centre Hospitalier Universitaire Va
Rue du Bugnon
CH-1011 Lausanne
+41 21 314 49 79
gilbert.greub@chuv.ch

Implementation Partner

Danuta Cichocka
Resistell AG
Hofackerstrasse 40B
CH-4132 Muttenz
+41798999188
danuta.cichocka@resistell.com